Search alternatives:
table 27 » table 2a, tabelle 27, table 2.1
table 21 » table 2.1, table 11, table 2a
table b » table 3, table 4
table 27 » table 2a, tabelle 27, table 2.1
table 21 » table 2.1, table 11, table 2a
table b » table 3, table 4
|
by Whitlock, Evelyn P., Williams, Selvi, Burda, Brittany U., Feightner, Alisha
Published 2015
“...When restricted to all trials of 100 mg or less, the risk tended to decrease (OR, 1.32 [95% CI...”Published 2015
Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services
|
by Whitlock, Evelyn P., Williams, Selvi, Burda, Brittany U., Feightner, Alisha
Published 2015
“...When restricted to all trials of 100 mg or less, the risk tended to decrease (OR, 1.32 [95% CI...”Published 2015
Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services
|
by Patnode, Carrie D., Perdue, Leslie A., Rushkin, Megan, O'Connor, Elizabeth A.
Published 2020
“... of each tool has not been evaluated in more than one study and there is no evidence on the benefits...”Published 2020
Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services
|
by Patnode, Carrie D., Perdue, Leslie A., Rushkin, Megan, O'Connor, Elizabeth A.
Published 2020
“... of each tool has not been evaluated in more than one study and there is no evidence on the benefits...”Published 2020
Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services